We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

134 hedge funds and large institutions have $384M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $376M → $384M (+$8.43M)

2% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 43

2% less funds holding

Funds holding: 137 → 134 (-3)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

18% less call options, than puts

Call options by funds: $5.11M | Put options by funds: $6.21M

Holders
134
Holders Change
-3
Holders Change %
-2.19%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
42
Reduced
43
Closed
18
Calls
$5.11M
Puts
$6.21M
Net Calls
-$1.1M
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$6.06M
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$1.44M
3
HF
HRT Financial
New York
+$1.32M
4
Millennium Management
Millennium Management
New York
+$1.28M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$575K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$19.6M
2
BlackRock
BlackRock
New York
-$3.17M
3
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.67M
4
UBS Group
UBS Group
Switzerland
-$1.57M
5
Citigroup
Citigroup
New York
-$1.23M

VBIV Hedge Fund Activity: Q2 2021 in Review

134 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q2 2021, worth a combined $384M — up 2.2% from $376M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of VBIV and 16 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 42 added.

The largest buyer was Citadel Advisors, adding an estimated $6.06M. The largest seller was State Street, cutting an estimated $19.6M.

  • 134 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q2 2021, down from 137 in Q1 2021.
  • Funds reported $384M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q2 2021, up 2.2% quarter-over-quarter.
  • 16 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q2 2021 and 18 closed out, a net change of -2 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q2 2021 was Citadel Advisors, an estimated $6.06M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q2 2021 was State Street, an estimated $19.6M sold.

Based on aggregated 13F filings for Q2 2021.